Measles resurgence in southern Africa: challenges to measles elimination (Q30217282)

10 June 2017

Measles resurgence in southern Africa: challenges to measles elimination (English)

1 reference

10 June 2017

0 references

1 reference

Messeret E Shibeshi

1

1 reference

10 June 2017

Balcha G Masresha

2

1 reference

10 June 2017

Sheilagh B Smit

3

1 reference

10 June 2017

Robin J Biellik

4

1 reference

10 June 2017

Jennifer L Nicholson

5

1 reference

10 June 2017

Charles Muitherero

6

1 reference

10 June 2017

Nestor Shivute

7

1 reference

10 June 2017

Oladapo Walker

8

1 reference

10 June 2017

Katsande Reggis

9

1 reference

10 June 2017

James L Goodson

10

1 reference

10 June 2017

language of work or name

English

0 references

publication date

13 February 2014

1 reference

10 June 2017

1 reference

10 June 2017

32

1 reference

10 June 2017

16

1 reference

10 June 2017

1798-1807

1 reference

Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study

10 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

The Americas: paving the road toward global measles eradication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Elimination of rubella and congenital rubella syndrome in the Americas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Measles and rubella eradication in the Americas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

First 5 years of measles elimination in southern Africa: 1996-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Lessons and challenges for measles control from unexpected large outbreak, Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

WHO and UNICEF estimates of national infant immunization coverage: methods and processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

A formal representation of the WHO and UNICEF estimates of national immunization coverage: a computational logic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Research priorities for global measles and rubella control and eradication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Immunity to measles in pregnant mothers and in cord blood of their infants: impact of HIV status and mother's place of birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Changing epidemiology of measles in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

Rubella epidemiology in Africa in the prevaccine era, 2002-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.089

10.1016/J.VACCINE.2014.01.089

7 January 2021

Identifiers

DOI

1 reference

10 June 2017

1 reference